Solventum
$87.85Change from previous close: +0.09%Absolute change: +$0.08
At a glance
- Revenue growth
- +0.86%
- 2025 vs 2024
- Net income growth
- +224.84%
- 2025 vs 2024
- Net margin
- 18.7%
- 2024: 5.8%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 8,325 | 8,254 | 8,197 | 8,130 | — |
| Cost of revenue | 3,874 | 3,661 | 3,504 | 3,435 | — |
| Gross profit | 4,451 | 4,593 | 4,693 | 4,695 | — |
| Selling, general and administrative | 3,080 | 2,782 | 2,299 | 2,235 | — |
| Research and development | 739 | 775 | 758 | 767 | — |
| Operating income | 632 | 1,036 | 1,636 | 1,693 | — |
| EBIT | 2,060 | 972 | 1,667 | 1,692 | — |
| EBITDA | 2,549 | 1,527 | 2,228 | 2,270 | — |
| Interest expense | 347 | 367 | 0.0 | 0.0 | — |
| Pre-tax income | 1,713 | 605 | 1,667 | 1,692 | — |
| Income tax | 157 | 127 | 321 | 349 | — |
| Net income | 1,556 | 479 | 1,346 | 1,343 | — |
| Net income to common shareholders | 1,556 | 479 | 1,346 | 1,343 | — |
| Basic EPS | 8.94 | 2.77 | 7.79 | 7.78 | — |
| Diluted EPS | 8.88 | 2.76 | 7.79 | 7.78 | — |
| Average shares (basic) | 174 | 173 | 173 | 173 | — |
| Average shares (diluted) | 175 | 174 | 173 | 173 | — |